Last Updated: August 2, 2026

LEUCOVORIN CALCIUM Drug Patent Profile

✉ Email this page to a colleague

« Back to Dashboard

Which patents cover Leucovorin Calcium, and when can generic versions of Leucovorin Calcium launch?

Leucovorin Calcium is a drug marketed by Hospira, Abic, Abraxis Pharm, Elkins Sinn, Gland, Hainan Poly, Hikma, Meitheal, Pharmachemie, Pharmachemie Usa, Teva Parenteral, Teva Pharms Usa, Fresenius Kabi Usa, Ingenus Pharms Llc, Ani Pharms, Barr, Epic Pharma Llc, Leading, Par Pharm, Xanodyne Pharm, Am Regent, Mylan Labs Ltd, Sagent Pharms, and Sagent Pharms Inc. and is included in forty-nine NDAs.

The generic ingredient in LEUCOVORIN CALCIUM is leucovorin calcium. There are nine drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the leucovorin calcium profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Leucovorin Calcium

A generic version of LEUCOVORIN CALCIUM was approved as leucovorin calcium by HIKMA on September 14^th, 1987.

Start Trial

AI Deep Research

Questions you can ask:

What is the 5 year forecast for LEUCOVORIN CALCIUM?
What are the global sales for LEUCOVORIN CALCIUM?
What is Average Wholesale Price for LEUCOVORIN CALCIUM?

Summary for LEUCOVORIN CALCIUM

US Patents:	0
Applicants:	24
NDAs:	49

US Patents and Regulatory Information for LEUCOVORIN CALCIUM

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Hikma	LEUCOVORIN CALCIUM PRESERVATIVE FREE	leucovorin calcium	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	040347-001	Apr 25, 2000		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Hikma	LEUCOVORIN CALCIUM	leucovorin calcium	TABLET;ORAL	072734-001	Feb 22, 1993	AB	RX	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
Ingenus Pharms Llc	LEUCOVORIN CALCIUM	leucovorin calcium	SOLUTION;INTRAMUSCULAR, INTRAVENOUS	210917-001	Nov 23, 2018		DISCN	No	No	⤷ Start Trial	⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.